| (V1550) |
Lower T waves in non-standard precordial ECG recordings are linked with the occurrence of Torsades de pointes in patients with congenital long QT syndrome |
|
A. Samol, H.-J. Bruns, S. Zumhagen, M. Paul, G. Frommeyer, S. Kochhäuser, E. Schulze-Bahr, L. Eckardt, G. Mönnig (Münster, Ampfing) |
| (V1551) |
Further evidence for the beneficial role of flecainide in catecholaminergic polymorphic ventricular tachycardia: A clinical case and effects on Na+/Ca2+ exchanger inward current |
|
C. Pott, N. Bögeholz, A. Muszynski, P. Milberg, S. Zellerhoff, G. Mönnig, D. Dechering, F. Reinke, J. Köbe, E. Schulze-Bahr, J. I. Goldhaber, K. Philipson, L. Eckardt (Münster; Los Angeles, US) |
| (V1552) |
Establishment of a mouse model for human Brugada syndrome: In vivo analysis of the SCN5A loss-of-function mutation G1408R |
|
T. Fink, P. Yampolsky, M. Koenen, R. Becker, H. A. Katus, D. Thomas, P. Schweizer (Heidelberg) |
| (V1553) |
Identification and functional characterization of the novel hERG R744P mutant associated with hereditary long QT syndrome 2 |
|
P. Aidery, J. Kisselbach, I. Baldea, P. Schweizer, R. Becker, H. A. Katus, D. Thomas (Heidelberg) |
| (V1554) |
Genotype-phenotype relations in a large set of patients with congenital long QT syndrome 1 (LQT-1). |
|
S. Zumhagen, J. Büring, C. Friedrich, A. Husemann, G. Mönnig, B. Stallmeyer, E. Schulze-Bahr (Münster, Coesfeld) |
| (V1555) |
Tpeak-Tend interval and Tpeak-Tend/QT ratio in lead V1 as potentially non-invasive cardiac risk markers in patients with Brugada syndrome. |
|
S. Zumhagen, E. M. Pech, B. Stallmeyer, L. Eckardt, E. Schulze-Bahr (Münster, Hamburg) |